A New Prognostic Risk Signature of Eight Ferroptosis-Related Genes in the Clear Cell Renal Cell Carcinoma

Clear cell renal cell carcinoma (ccRCC) is the most common renal cell carcinoma and has poor prognosis in the locally advanced stage. Ferroptosis, a relatively new type of cell death, has gained significant attention in recent years. This study aimed to explore the prognostic value of ferroptosis-re...

Full description

Bibliographic Details
Main Authors: Ji Chen, Yating Zhan, Rongrong Zhang, Bo Chen, Junting Huang, Chunxue Li, Wenjie Zhang, Yajing Wang, Yuxiang Gao, Jianjian Zheng, Yeping Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.700084/full
id doaj-5d93edd50ae345a3978e67f6f97fcb36
record_format Article
spelling doaj-5d93edd50ae345a3978e67f6f97fcb362021-06-25T06:31:58ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2021-06-011110.3389/fonc.2021.700084700084A New Prognostic Risk Signature of Eight Ferroptosis-Related Genes in the Clear Cell Renal Cell CarcinomaJi Chen0Yating Zhan1Rongrong Zhang2Bo Chen3Junting Huang4Chunxue Li5Wenjie Zhang6Yajing Wang7Yuxiang Gao8Jianjian Zheng9Yeping Li10Key Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, ChinaKey Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, ChinaKey Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, ChinaKey Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, ChinaKey Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, ChinaKey Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, ChinaKey Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, ChinaKey Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, ChinaKey Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, ChinaKey Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, ChinaDepartment of Urology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, ChinaClear cell renal cell carcinoma (ccRCC) is the most common renal cell carcinoma and has poor prognosis in the locally advanced stage. Ferroptosis, a relatively new type of cell death, has gained significant attention in recent years. This study aimed to explore the prognostic value of ferroptosis-related genes (FRGs) in ccRCC. In this study, 50 differentially expressed FRGs between ccRCC and adjacent normal kidney tissues were identified, 26 of them correlated with overall survival (OS) (P <0.05). Eight optimal FRGs were selected by Lasso regression and multivariate Cox regression analysis, and used to construct a new prognostic risk signature to predict the prognosis of ccRCC patients. In addition, the signature passed the validation of prognostic survival analyses by a significant margin, and the risk score was identified as an independent prognostic marker via Cox regression analyses. Further studies indicated that the signature was significantly correlated with immune cell infiltration. Moreover, the levels of eight FRGs were examined in ccRCC. Collectively, the 8-FRG prognostic risk signature helps the clinicians predict the prognosis and OS of the patients, and standardize prognostic assessments.https://www.frontiersin.org/articles/10.3389/fonc.2021.700084/fullTCGA databaseferroptosisccRCCprognosis signatureimmune infiltration
collection DOAJ
language English
format Article
sources DOAJ
author Ji Chen
Yating Zhan
Rongrong Zhang
Bo Chen
Junting Huang
Chunxue Li
Wenjie Zhang
Yajing Wang
Yuxiang Gao
Jianjian Zheng
Yeping Li
spellingShingle Ji Chen
Yating Zhan
Rongrong Zhang
Bo Chen
Junting Huang
Chunxue Li
Wenjie Zhang
Yajing Wang
Yuxiang Gao
Jianjian Zheng
Yeping Li
A New Prognostic Risk Signature of Eight Ferroptosis-Related Genes in the Clear Cell Renal Cell Carcinoma
Frontiers in Oncology
TCGA database
ferroptosis
ccRCC
prognosis signature
immune infiltration
author_facet Ji Chen
Yating Zhan
Rongrong Zhang
Bo Chen
Junting Huang
Chunxue Li
Wenjie Zhang
Yajing Wang
Yuxiang Gao
Jianjian Zheng
Yeping Li
author_sort Ji Chen
title A New Prognostic Risk Signature of Eight Ferroptosis-Related Genes in the Clear Cell Renal Cell Carcinoma
title_short A New Prognostic Risk Signature of Eight Ferroptosis-Related Genes in the Clear Cell Renal Cell Carcinoma
title_full A New Prognostic Risk Signature of Eight Ferroptosis-Related Genes in the Clear Cell Renal Cell Carcinoma
title_fullStr A New Prognostic Risk Signature of Eight Ferroptosis-Related Genes in the Clear Cell Renal Cell Carcinoma
title_full_unstemmed A New Prognostic Risk Signature of Eight Ferroptosis-Related Genes in the Clear Cell Renal Cell Carcinoma
title_sort new prognostic risk signature of eight ferroptosis-related genes in the clear cell renal cell carcinoma
publisher Frontiers Media S.A.
series Frontiers in Oncology
issn 2234-943X
publishDate 2021-06-01
description Clear cell renal cell carcinoma (ccRCC) is the most common renal cell carcinoma and has poor prognosis in the locally advanced stage. Ferroptosis, a relatively new type of cell death, has gained significant attention in recent years. This study aimed to explore the prognostic value of ferroptosis-related genes (FRGs) in ccRCC. In this study, 50 differentially expressed FRGs between ccRCC and adjacent normal kidney tissues were identified, 26 of them correlated with overall survival (OS) (P <0.05). Eight optimal FRGs were selected by Lasso regression and multivariate Cox regression analysis, and used to construct a new prognostic risk signature to predict the prognosis of ccRCC patients. In addition, the signature passed the validation of prognostic survival analyses by a significant margin, and the risk score was identified as an independent prognostic marker via Cox regression analyses. Further studies indicated that the signature was significantly correlated with immune cell infiltration. Moreover, the levels of eight FRGs were examined in ccRCC. Collectively, the 8-FRG prognostic risk signature helps the clinicians predict the prognosis and OS of the patients, and standardize prognostic assessments.
topic TCGA database
ferroptosis
ccRCC
prognosis signature
immune infiltration
url https://www.frontiersin.org/articles/10.3389/fonc.2021.700084/full
work_keys_str_mv AT jichen anewprognosticrisksignatureofeightferroptosisrelatedgenesintheclearcellrenalcellcarcinoma
AT yatingzhan anewprognosticrisksignatureofeightferroptosisrelatedgenesintheclearcellrenalcellcarcinoma
AT rongrongzhang anewprognosticrisksignatureofeightferroptosisrelatedgenesintheclearcellrenalcellcarcinoma
AT bochen anewprognosticrisksignatureofeightferroptosisrelatedgenesintheclearcellrenalcellcarcinoma
AT juntinghuang anewprognosticrisksignatureofeightferroptosisrelatedgenesintheclearcellrenalcellcarcinoma
AT chunxueli anewprognosticrisksignatureofeightferroptosisrelatedgenesintheclearcellrenalcellcarcinoma
AT wenjiezhang anewprognosticrisksignatureofeightferroptosisrelatedgenesintheclearcellrenalcellcarcinoma
AT yajingwang anewprognosticrisksignatureofeightferroptosisrelatedgenesintheclearcellrenalcellcarcinoma
AT yuxianggao anewprognosticrisksignatureofeightferroptosisrelatedgenesintheclearcellrenalcellcarcinoma
AT jianjianzheng anewprognosticrisksignatureofeightferroptosisrelatedgenesintheclearcellrenalcellcarcinoma
AT yepingli anewprognosticrisksignatureofeightferroptosisrelatedgenesintheclearcellrenalcellcarcinoma
AT jichen newprognosticrisksignatureofeightferroptosisrelatedgenesintheclearcellrenalcellcarcinoma
AT yatingzhan newprognosticrisksignatureofeightferroptosisrelatedgenesintheclearcellrenalcellcarcinoma
AT rongrongzhang newprognosticrisksignatureofeightferroptosisrelatedgenesintheclearcellrenalcellcarcinoma
AT bochen newprognosticrisksignatureofeightferroptosisrelatedgenesintheclearcellrenalcellcarcinoma
AT juntinghuang newprognosticrisksignatureofeightferroptosisrelatedgenesintheclearcellrenalcellcarcinoma
AT chunxueli newprognosticrisksignatureofeightferroptosisrelatedgenesintheclearcellrenalcellcarcinoma
AT wenjiezhang newprognosticrisksignatureofeightferroptosisrelatedgenesintheclearcellrenalcellcarcinoma
AT yajingwang newprognosticrisksignatureofeightferroptosisrelatedgenesintheclearcellrenalcellcarcinoma
AT yuxianggao newprognosticrisksignatureofeightferroptosisrelatedgenesintheclearcellrenalcellcarcinoma
AT jianjianzheng newprognosticrisksignatureofeightferroptosisrelatedgenesintheclearcellrenalcellcarcinoma
AT yepingli newprognosticrisksignatureofeightferroptosisrelatedgenesintheclearcellrenalcellcarcinoma
_version_ 1721360238080163840